经腹腔与腹膜后途径机器人前哨淋巴结清扫用于疑似早期上皮性卵巢癌分期
本文通过两例临床病例展示机器人辅助前哨淋巴结活检(SLNB)在疑似早期上皮性卵巢癌分期中的经腹腔与腹膜后途径操作细节,并综述近期研究。分析显示汇总检出率较高但证据质量低,MELISA研究检出率、敏感性和特异性高于SELLY研究。SLNB目前仍限于临床试验,未来需标准化方案。
要点
- 机器人辅助SLNB可精细识别并定位前哨淋巴结,荧光引导有助于淋巴结识别。
- 近期分析与Meta分析显示汇总检出率较高,但证据质量低。
- MELISA研究显示检出率、敏感性和特异性均高于SELLY研究。
核心结论
- 机器人辅助SLNB在提高上皮性卵巢癌准确性和降低发病率方面显示出前景,但其应用仍限于临床试验。
- 未来研究应聚焦于制定标准化方案以获得一致结果,并为将其整合入常规临床实践提供充分证据。
研究设计与样本
- 本文通过两项临床病例研究展示机器人辅助SLNB的操作细节,并综合近期研究见解。
主要发现
- 近期分析与Meta分析显示汇总检出率较高,但证据质量低。
- MELISA研究显示检出率、敏感性和特异性均高于SELLY研究。
- 前哨淋巴结位置多变,需要细致探查。
- 腹膜后途径可能对腹主动脉旁淋巴结清扫有优势,尤其在肥胖患者中,但在前哨淋巴结活检中广泛清扫的需求可能限制其使用。
关键数值与推荐
- 关键技术方面包括注射区域和使用联合示踪剂。
临床怎么用
- SLNB尤其机器人辅助在提高上皮性卵巢癌准确性和降低发病率方面显示出前景,但其应用仍限于临床试验。
- 未来研究应聚焦于制定标准化方案以获得一致结果,并为将其整合入常规临床实践提供充分证据。
局限性
- 检出率可变。
- 缺乏标准化方案。
- 机器人技术的可及性。
- 需要高级手术技能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Epithelial ovarian cancer (EOC) is a significant global health concern. Early detection remains rare, with only 20% of cases identified at an early stage, highlighting the critical need for effective staging interventions [1]. Traditional extensive lymphadenectomy, associated with considerable morbidity, has led to the exploration of selective sentinel lymph node biopsy (SLNB), which is still under study [1-4]. METHODS: SLNB, enhanced by robotic technology, is demonstrated through two clinical case studies studies that show how robotic systems are used to meticulously identify and map sentinel nodes, focusing on procedural specifics and fluorescence-guided node identification. The article synthesizes insights from recent studies [1-4], emphasizing the integration of robotic technology with SLNB to enhance surgical precision, improve recovery, and reduce morbidity. DISCUSSION: We examine SLNB through retroperitoneal and transperitoneal approaches, highlighting technical aspects and the benefits of robotic assistance over conventional laparoscopy, such as improved precision and ergonomics. A recent analysis and meta-analysis [1] showed a high pooled detection rate, though the evidence quality is low. Recently, the MELISA [3] and SELLY [2] studies were published, with MELISA showing higher detection, sensitivity, and specificity rates than SELLY. Sentinel lymph nodes vary in location, requiring meticulous exploration [1]. The retroperitoneal approach might offer an advantage for para-aortic dissection, particularly in obese patients, however, in sentinel lymph node biopsy, the need for extensive dissection could potentially limit its use [5]. Key technique aspects include injection zones and using combined tracers [2]. Limitations include variable detection rates, lack of standardized protocols, accessibility to robotic technology, and the need for advanced surgical skills [1]. CONCLUSION: SLNB, particularly with robotic assistance, shows promise for improving accuracy and reducing morbidity in epithelial ovarian cancer. However, its use remains limited to clinical trials. Future studies should focus on developing standardized protocols to achieve consistent results and provide sufficient evidence for its integration into routine clinical practice.
引用
- Valenzuela-Méndez B, Bentivegna E, Bats AS, et al. Robotic Sentinel Lymph Node Dissection for Presumed Early-Stage Epithelial Ovarian Cancer Stadification by Transperitoneal and Retroperitoneal Approaches. J Minim Invasive Gynecol. 2025. PMID: 39952605. doi:10.1016/j.jmig.2024.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。